Pharma News

German chemical and pharmaceutical company Bayer AG has raised the price on the purchase of the American manufacturer of herbicides and genetically modified seeds Monsanto up to $127,5.

Merck ($MRK) is giving up on its delayed and long-troubled bone drug odanacatib after it became apparent the safety risk from using the experimental med was just too high.

BRIGHTON, UK I September 5, 2016 I Destiny Pharma Ltd, a leading clinical stage biopharmaceutical company focused on developing antibacterial medicines, today announced the results of a US clinical tr...

Hillary Clinton said on Friday that if elected to the White House she would create an oversight panel to protect U.

From Zacks Research.

Netherlands-incorporated Mylan (Nasdaq.

August 31, 2016 -- The U.

In a recent study researchers have discovered a type of drug delivery system that may offer new hope for patients with a rare, ultimately fatal genetic disorder Niemann Pick Type C1 and make what migh...

Taking a cue from science fiction, Israeli researchers have invented mind-controlled nanobots that have the potential to treat “challenging” brain disorders, the UK’s Daily Mail reported.

Florida officials on Thursday said they have trapped the first mosquitoes that tested positive for the Zika virus in the Miami area, further confirming reports of local U.

The infectious diseases point-of-care testing (POCT) market is set to rise from $696.

Novo Nordisk's long-serving chief executive Lars Rebien Sorensen is to step down early, it was announced on Thursday, at a time when the world's largest insulin maker has said it faces increas...